Cargando…
Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135005/ https://www.ncbi.nlm.nih.gov/pubmed/30214654 http://dx.doi.org/10.14740/jocmr3587w |
| _version_ | 1783354768228352000 |
|---|---|
| author | Yanagawa, Tatsuo |
| author_facet | Yanagawa, Tatsuo |
| author_sort | Yanagawa, Tatsuo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6135005 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elmer Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61350052018-09-13 Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors Yanagawa, Tatsuo J Clin Med Res Letter to the Editor Elmer Press 2018-10 2018-09-10 /pmc/articles/PMC6135005/ /pubmed/30214654 http://dx.doi.org/10.14740/jocmr3587w Text en Copyright 2018, Yanagawa http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Yanagawa, Tatsuo Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title | Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title_full | Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title_fullStr | Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title_full_unstemmed | Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title_short | Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors |
| title_sort | strong association between weight reduction and suppression of cardiovascular events in recent clinical trials of dpp4 inhibitors, glp-1 receptor agonists, and sglt2 inhibitors |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135005/ https://www.ncbi.nlm.nih.gov/pubmed/30214654 http://dx.doi.org/10.14740/jocmr3587w |
| work_keys_str_mv | AT yanagawatatsuo strongassociationbetweenweightreductionandsuppressionofcardiovasculareventsinrecentclinicaltrialsofdpp4inhibitorsglp1receptoragonistsandsglt2inhibitors |